Strategic advice & regulatory analysis

Our experienced consultants can provide ad-hoc insight on any regulatory requirements for France and address any questions in particular related to:

  • Drug Registration,
  • Early Access Programmes,
  • Post MAA activities,
  • Promotional material review,
  • Quality System & Audits,
  • Interactions with Healthcare professionals: Compliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
  • Pharmacovigilance,
  • Pricing & reimbursement.

Discover our last white Paper

Learn more